CD79A has been demonstrated to play diverse roles in the development and function of B lymphocytes (Pelanda et al., 2002) and may be downregulated in severe COPD when compared with controls (Cockayne et al., 2011). Here, CD79A is linked to chronic obstructive pulmonary disease.